EUPRAXIA PHARMACEUTICALS INC. - Common Shares, with no par value (EPRX)

Historical Holders from Q2 2024 to Q3 2025

Symbol
EPRX on Nasdaq
CUSIP
29842P105
Type / Class
Equity / Common Shares, with no par value
Shares outstanding
51M
All holders as of September 30, 2025
Q3 2025
Total 13F shares, excl. options
12.8M
Holdings value
$75.3M
% of all portfolios
0.001%
Grand Portfolio weight change
+0%
Number of holders
27
Number of buys
22
Number of sells
-4
Average Value change %
+0%
Average buys %
+0.001%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of EUPRAXIA PHARMACEUTICALS INC. - Common Shares, with no par value (EPRX)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
MANCHESTER MANAGEMENT CO LLC 10.9% $34.5M 5.84M JAMES E. BESSER Dec 31, 2024
Freedman Joseph S. 10.2% $29.2M 5.53M Joseph S. Freedman Sep 24, 2025
Beutel, Goodman & Co Ltd. 8% $23.9M 4.06M Beutel, Goodman & Co Ltd. Sep 30, 2025
DISBROW ROBERT 7% $21.1M 3.57M Robert Disbrow Sep 30, 2025

Institutional Holders of EUPRAXIA PHARMACEUTICALS INC. - Common Shares, with no par value (EPRX)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 12.8M $75.3M +$64M $5.90 27
2025 Q2 1.97M $10.9M -$1.05M $5.76 14
2025 Q1 2.17M $7.09M +$1.12M $3.28 11
2024 Q4 1.83M $5.63M +$50.5K $3.17 9
2024 Q3 1.8M $4.55M +$185K $2.63 8
2024 Q2 1.73M $4.43M +$4.43M $2.58 8